Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

Form Description Filing date View
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
FWP

FWP

View HTML
ARS

An annual report to security holders

View HTML
FWP

FWP

View HTML
S-1

Registration statement for face-amount certificate companies

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML

Copyright Morningstar



Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved